Donor Lymphocyte Infusion
4 clinical trials · Condition
◉ Watch Donor Lymphocyte Infusion
| Record | Firm | Date |
|---|---|---|
| Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies (NCT03771222) | Chinese PLA General Hospital | 2019-01-01 |
| Exercise as an Immune Adjuvant for Allogeneic Cell Therapies (NCT06643221) | University of Arizona | 2018-01-24 |
| Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant (NCT03297528) | Peking University People's Hospital | 2017-03-01 |
| MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT (NCT02673008) | Nanfang Hospital, Southern Medical University | 2016-01-01 |
Track Donor Lymphocyte Infusion automatically
Every clearance here is in the API, with alerts when new ones post.